Abstract
Get full access to this article
View all access options for this article.
References
1.
Frangoul
H
,
Altshuler
D
,
Cappellini
MD
et al. CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia . N Engl J Med , 2021 ; 384 :252 –260 ; doi: 10.1056/NEJMoa2031054